Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Dementia Treatment Market Grown from 2024 to 2025?
The market size for dementia treatment has been on a robust growth trajectory in recent years. This growth is set to continue, rising from a valuation of $18.32 billion in 2024 to an estimated value of $20.14 billion in 2025, representing a compound annual growth rate (CAGR) of 9.9%. Factors contributing to growth during the historic period include an aging demographic, better rates of diagnosis, increased awareness, growth in healthcare infrastructure, and increased investments by governments towards dementia-related research and treatment.
What Growth Rate Is Anticipated for the Dementia Treatment Market in the Coming Years?
The market size for dementia treatment is predicted to experience substantial growth in the upcoming years, increasing to a valuation of $29.12 billion by 2029 with a compound annual growth rate (CAGR) of 9.7%. The rise during that period could be credited to factors such as increased spending on healthcare, a greater frequency of chronic illnesses, an uptick in clinical trials, an expanding pharmaceutical industry, and climbing Alzheimer’s disease rates. Noteworthy developments forecasted for this period consist of advancements in scientific research, the application of artificial intelligence and machine learning in diagnosis and treatment processes, the emergence of innovative drugs and therapies, investments pumped into biotechnology, and progress in creating personalized treatment approaches.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24200&type=smp
Who Are the Leading Companies in the Dementia Treatment Market?
Major companies operating in the dementia treatment market are Roche Holding AG, AbbVie Inc., Sanofi S.A., Eli Lilly and Company, Amgen Inc., Biogen Inc., Eisai Co. Ltd., Merz Pharmaceuticals GmbH, Acadia Pharmaceuticals Inc., Intra-Cellular Therapies Inc., Cerevance Inc., Retro Biosciences Inc., AviadoBio Ltd., MapHabit Inc., Neuvivo Inc., Harmonic Health Inc., Rippl Care Inc., Isaac Health Inc., EmTech Care Labs Inc., LifeBio Inc.
What Are the Key Drivers of the Dementia Treatment Market?
The escalating occurrence of neurodegenerative conditions is anticipated to fuel the expansion of the dementia treatment market in the upcoming years. Neurodegenerative disorders, characterized by the gradual deterioration and loss of nerve cells, typically result in progressive movement or cognitive issues, or both. The surge in these disorders is primarily attributed to the aging population, as extended lifespans lead to a higher risk of developing age-related illnesses like Alzheimer’s and Parkinson’s disease, with age being the major contributing factor. A better comprehension of neurodegenerative disorders improves dementia treatment by facilitating accurate diagnosis and specialized therapies. Recognizing the precise underlying disorder allows for a more personalized and effective strategy for symptom management. For example, a report from the Alzheimer’s Association, a US-based non-profit health organization, revealed in April 2024 that approximately 6.9 million Americans aged 65 and above suffered from Alzheimer’s dementia. This number is projected to double, reaching 13.8 million by 2060. Therefore, the escalating incidence of neurodegenerative disorders will propel the growth of the dementia treatment market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24200&type=smp
What Are the Key Market Segments in the Dementia Treatment Industry?
The dementia treatment market covered in this report is segmented –
1) By Treatment Type: Antipsychotics, Cholinesterase Inhibitors, Memantine, Other Treatment Types
2) By Indication: Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia, Parkinson Disease Dementia, Other Indications
3) By Route of Administration: Oral, Transdermal Patch, Injectable
4) By Stage of Dementia: Mild Dementia, Moderate Dementia, Severe Dementia
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Antipsychotics: Atypical Antipsychotics, Typical Antipsychotics
2) By Cholinesterase Inhibitors: Donepezil, Rivastigmine, Galantamine
3) By Memantine: Memantine Monotherapy, Memantine Combination Therapy
4) By Other Treatment Types: Cognitive Enhancers, NMDA Receptor Antagonists, Nutritional And Herbal Supplements, Hormonal Treatments, Stem Cell Therapy
What Are the Latest Trends in the Dementia Treatment Market?
Prominent organizations within the dementia treatment arena are placing emphasis on the creation of technologically superior solutions, like virtual reality (VR) training activities, to mimic a range of intricate situations. These VR training activities represent engaging, computer-generated emulations that allow persons to rehearse and refine skills within a controlled, interactive, and authentic virtual milieu. For example, Otsuka Pharmaceutical Co. Ltd., a pharmaceutical entity based in Japan, forged a partnership with Jolly Good Inc., a medical technology company from Japan, in September 2024 to launch FACEDUO, a VR training scheme for dementia care. Expert medical practitioners guide this interactive VR platform, which aids caregivers, including family members, in interpreting the feelings and actions of people affected by dementia. The replication of lifelike situations equips caregivers with the necessary tools to cater to the distinct needs of dementia patients better. The initiative seeks to sharpen caregiving skills and foster greater empathy for more effective assistance.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/dementia-treatment-global-market-report
What Are the Key Regional Markets in the Dementia Treatment Industry?
North America was the largest region in the dementia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dementia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/customise?id=24200&type=smp
This Report Delivers Insight On:
1. How big is the dementia treatment market, and how is it changing globally?
2. Who are the major companies in the dementia treatment market, and how are they performing?
3. What are the key opportunities and risks in the dementia treatment market right now?
4. Which products or customer segments are growing the most in the dementia treatment market?
5. What factors are helping or slowing down the growth of the dementia treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model